Skip to main content

Table 2 Adjusted associations (risk ratio, 95% confidence interval) of independent variables with Lyme disease stage (disseminated vs. early stage)

From: Risk factors for Lyme disease stage and manifestation using electronic health records

 

All disseminated vs. early Lyme disease

Disseminated manifestation vs. early Lyme disease

Arthritis

Neurological manifestations

Carditis

Secondary erythema migrans

Other disseminated

1379/3151 (disseminated vs. early)

762/3151 (arthritis vs. early)

426/3151 (neurological vs. early)

76/2446a (carditis vs. early)

95/3120a (secondary erythema migrans vs. early)

76/3151 (other disseminated vs. early)

Age (years)

 0 to < 10

1.24 (1.08, 1.42)

1.25 (1.05, 1.48)

1.04 (0.77, 1.39)

0.39 (0.13, 1.21)

2.59 (1.47, 4.57)

2.66 (1.33, 5.35)

 10 to < 20

1.44 (1.28, 1.63)

1.38 (1.16, 1.63)

1.61 (1.24, 2.10)

1.45 (0.83, 2.55)

2.41 (1.26, 4.58)

2.56 (1.23, 5.34)

 20 to < 30

1.21 (1.00, 1.46)

1.16 (0.89, 1.51)

1.41 (0.99, 2.02)

2.01 (0.94, 4.31)

1.54 (0.63, 3.75)

0.31 (0.04, 2.19)

 30 to < 50

1.13 (0.99, 1.29)

0.99 (0.82, 1.21)

1.39 (1.09, 1.77)

1.30 (0.75, 2.24)

0.64 (0.30, 1.36)

1.30 (0.64, 2.65)

 50 to < 70

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

70+

1.14 (0.96, 1.35)

1.13 (0.88, 1.47)

1.08 (0.77, 1.53)

1.00 (0.43, 2.36)

1.57 (0.73, 3.38)

1.20 (0.46, 3.08)

Sex

 Male

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

 Female

1.01 (0.93, 1.09)

1.00 (0.89, 1.12)

1.06 (0.90, 1.25)

0.94 (0.55, 1.61)

1.20 (0.83, 1.74)

1.40 (0.88, 2.21)

Race/ethnicity

 White

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

 Non-White

1.25 (0.93, 1.67)

1.18 (0.78, 1.80)

1.33 (0.71, 2.49)

NA

0.93 (0.13, 6.57)

2.07 (0.72, 5.98)

Medical assistance

 0% time

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

 > 0% to < 50% time

0.97 (0.85, 1.11)

0.94 (0.78, 1.14)

0.87 (0.65, 1.16)

1.03 (0.56, 1.89)

0.85 (0.48, 1.49)

1.66 (0.97, 2.84)

 ≥ 50% time

1.20 (1.05, 1.37)

1.37 (1.15, 1.64)

1.22 (0.93, 1.60)

1.04 (0.47, 2.27)

0.54 (0.24, 1.22)

0.15 (0.02, 1.16)

Primary care contact

 No

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

 Yes

0.59 (0.54, 0.64)

0.55 (0.48, 0.63)

0.44 (0.36, 0.54)

0.51 (0.30, 0.86)

0.75 (0.42, 1.34)

0.13 (0.08, 0.20)

Setting of diagnosis

 Outpatient

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

 Urgent care

0.22 (0.17, 0.29)

0.22 (0.15, 0.31)

0.12 (0.06, 0.21)

NA

0.47 (0.23, 0.93)

0.027 (0.003, 0.21)

 Emergency

1.04 (0.85, 1.27)

0.73 (0.50, 1.06)

1.49 (1.09, 2.04)

1.30 (0.48, 3.54)

0.87 (0.31, 2.45)

0.51 (0.16, 1.60)

 Inpatient

2.21 (1.98, 2.47)

1.88 (1.49, 2.36)

4.12 (3.30, 5.14)

25.4 (15.22, 42.50)

NA

3.84 (1.59, 9.25)

Season of diagnosis

 Winter (Dec–Feb)

2.19 (1.96, 2.45)

4.54 (3.84, 5.37)

1.45 (1.03, 2.03)

0.78 (0.25, 2.41)

1.17 (0.44, 3.17)

1.25 (0.54, 2.91)

 Spring (March–May)

1.35 (1.18, 1.54)

2.53 (2.10, 3.04)

0.77 (0.57, 1.05)

0.70 (0.25, 1.97)

0.69 (0.34, 1.39)

0.34 (0.11, 1.06)

 Summer (June–Aug)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

 Fall (Sept–Nov)

1.46 (1.33, 1.62)

2.75 (2.35, 3.22)

0.84 (0.67, 1.07)

1.31 (0.80, 2.16)

0.75 (0.42, 1.33)

0.92 (0.54, 1.56)

Urban/rural residence

 Rural

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

1.00 (Reference)

 Urban cluster

1.10 (0.99, 1.22)

1.13 (0.97, 1.32)

1.20 (0.95, 1.52)

1.29 (0.70, 2.39)

1.33 (0.83, 2.14)

1.18 (0.66, 2.13)

 Urbanized area

1.09 (0.98, 1.21)

1.09 (0.94, 1.26)

1.11 (0.90, 1.38)

1.42 (0.95, 2.12)

0.95 (0.54, 1.68)

1.32 (0.77, 2.26)

  1. NA not available
  2. aNo persons with Lyme carditis were non-White and none were diagnosed in the urgent care setting; therefore, non-cases (i.e., early stage cases) who were Non-White or diagnosed in the urgent care setting were excluded from the carditis model. No persons with secondary erythema migrans were diagnosed in the inpatient setting; therefore, early stage cases who were diagnosed in the inpatient setting were excluded from the secondary erythema migrans model